Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 08, 2024 07:45 ET | Source: BioRestorative Therapies, Inc

BioRestorative Therapies Partners with Galen Patient Recruitment to Accelerate Completion of Enrollment in Phase 2 Trial of BRTX-100 in Chronic Lumbar Disc Disease

— Collaboration follows recent manufacturing/clinical process enhancements that have tripled monthly trial capacity — — Patient enrollment expected to be completed in 2024 — ...
June 13, 2022 07:00 ET | Source: BioRestorative Therapies, Inc

BioRestorative Therapies Announces Clinical Site Initiation for the Company’s Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (cLDD)

-- First Site Will Enroll First Patient in the Clinical Study-- MELVILLE, NY., June 13, 2022 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ:...
November 10, 2021 06:00 ET | Source: BioRestorative Therapies, Inc

BioRestorative Therapies Appoints Robert Kristal as Chief Financial Officer

MELVILLE, N.Y., Nov. 10, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (NASDAQ:BRTX), a life sciences company focused on adult stem cell-based therapies, today announced...
November 04, 2021 21:21 ET | Source: BioRestorative Therapies, Inc

BioRestorative Therapies Prices $23 Million Public Offering and Uplisting to the Nasdaq Capital Market

Common stock will begin trading on The Nasdaq Capital Market under the ticker symbol “BRTX” November 5, 2021 MELVILLE, N.Y., Nov. 04, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc....
September 02, 2021 09:00 ET | Source: BioRestorative Therapies, Inc

BioRestorative Therapies Receives Patent in Australia Related to its Off-the-Shelf ThermoStem® Program

Issued Patent Grants Protection for an Implantable Scaffold using Brown Adipose Derived Stem Cells and Methods of Use MELVILLE, N.Y., Sept. 02, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies,...
August 31, 2021 09:00 ET | Source: BioRestorative Therapies, Inc

BioRestorative Therapies Receives Patent in Japan Related to its Off-the-Shelf ThermoStem® Program

Patent Issued Grants Protection for Deriving Brown Adipocytes from Brown Adipose (Fat)-Derived Stem Cells MELVILLE, N.Y., Aug. 31, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the...
June 07, 2021 06:00 ET | Source: BioRestorative Therapies, Inc

BioRestorative Therapies to Present at the Emerging Growth Conference on June 9, 2021

BioRestorative Therapies invites individual and institutional investors, as well as advisors and analysts, to attend its real-time, interactive presentation at the online Emerging Growth Conference. ...
May 10, 2021 06:00 ET | Source: BioRestorative Therapies, Inc

BioRestorative Therapies Expanding its Cell Therapy Manufacturing Facility

MELVILLE, N.Y., May 10, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today...
October 23, 2019 09:45 ET | Source: BioRestorative Therapies, Inc.

BioRestorative Therapies Receives A Second Patent in Australia For Its Metabolic Program

MELVILLE, N.Y., Oct. 23, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that the...